翻訳待ち：Moving AI from Paralysis to Production in Regulated Enterprises

AI サービスが一時的に利用できないため、復旧後に翻訳を補完します。

This (article/interview analysis) is sponsored by Elephant Ventures and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. Across banking, financial services, and pharma, AI ambition continues to outpace AI deployment. RAND Corporation found that more than 80 percent of AI projects fail — twice the failure rate of information technology projects that do not involve AI. The same research reported that 84 percent of business leaders believe AI will significantly impact their business and 97 percent feel rising urgency to deploy it; only 14 percent of organizations consider themselves fully ready to integrate it. That gap between conviction and readiness is exactly where regulated enterprises lose the most time and budget. The problem compounds in regulated sectors, where governance is not optional friction but a structural requirement. The FDA maintains a public list specifically to track AI-enabled medical devices authorized for marketing in the United States, a sign of how thorough oversight has been built into the deployment path for AI in life sciences. Meanwhile, the National Institute of Standards and Technology has launched listening sessions through its Center for AI Standards and Innovation specifically to gather sector-specific feedback on barriers to AI adoption in financial services, health care, and education — an acknowledgment, from the federal government’s own standards body, that regulated industries face adoption barriers distinct from the broader market. The real bottleneck isn’t ideas, talent, or even AI projects underway. It’s a repeatable way to get one of those projects past pilot and into production before the ground shifts again. Emerj recently published a series featuring Art Shectman, CEO of Elephant Ventures, exploring what regulated enterprises must put in place for agents to behave with expert‑level consistency and survive the realities of production. This article examines four insights that clarify how regulated enterprises can move AI from paralysis to production. Workflow trust as the prerequisite for AI reliability: AI only delivers dependable outcomes when it begins in workflows your organization already executes consistently, ensuring agents inherit stability rather than internal disagreement. Composable AI ecosystems as the cure for vendor overload: Categorizing your AI landscape into clear capability blocks lets leaders ignore most pitches and assemble only the essential components required to ship a working system. Atomic workflow slices as the practical unit of agent deployment: Decomposing complex regulated processes into small, unambiguous steps enables rapid agent rollout instead of multi‑year attempts to automate entire end‑to‑end workflows. Enterprise context singularity as the foundation for expert‑level agents: Centralizing regulatory nuance, domain logic, and historical decision patterns provides agents with the expert context needed to operate safely and deliver repeatable business results. Listen to the full episodes below: Episode 1:Breaking Free from AI Overwhelm in Banking and Financial Services – with Art Shectman of Elephant Ventures Episode 2: From Overwhelm to Working AI in Pharma and Life Sciences – with Art Shectman of Elephant Ventures Guest: Art Shectman, CEO and Founder of Elephant Ventures Expertise: Agentic AI, AI Transformation, Digital Strategy, Healthcare & Life Sciences Technology Brief Recognition: Art Shectman is a technology executive and entrepreneur with more than two decades of experience in digital transformation, software, and AI-driven innovation. He is the Founder and CEO of Elephant Ventures, where he leads the firm’s work with enterprise organizations across healthcare, life sciences, and financial services. Previously, Art co-founded Ultranauts, a quality engineering company focused on software testing and engineering services, where he served as President and continues to serve as a Board Member. Ultranauts has been recognized for its approach to neurodiverse talent and workplace innovation. Art is also an Edmund Hillary Fellow and holds a Bachelor of Science in Mechanical Engineering from MIT. Workflow trust as the prerequisite for AI reliability Art’s perspective clarifies a constraint many financial services leaders underestimate: AI does not stabilize a workflow — it mirrors it. Production‑grade agents must begin in work the organization already executes with consistency and predictable outcomes. Stable processes transfer that stability to the agent; contested or improvised workflows transfer fragmentation. As Art explains: “If you pick a workflow where your own people argue about the right way to do it, the agent will fail exactly the way your people fail. You have to start with the work your organization already trusts, because that’s the only path that survives the move to production.” — Art Shectman, CEO and Founder of Elephant Ventures This constraint becomes actionable through three selection criteria: Proven human executability: If a new hire cannot execute the workflow reliably within their first weeks, an agent will not execute it reliably either. This surfaces hidden complexity, undocumented steps, and reliance on tribal knowledge. Absence of internal disagreement: Any workflow where experts debate the correct approach is structurally unstable. AI will reproduce that ambiguity at scale, creating inconsistency rather than reliability. Deterministic boundaries: The workflow must have predictable inputs, defined outputs, and no hidden decision paths. Clear boundaries enable consistent agent performance; ambiguity degrades it. Leaders can apply these criteria through a simple selection sequence: 1. Identify workflows already executed with stable outcomes. These are the processes where teams produce consistent results without escalation or interpretation. 2. Remove workflows with unresolved expert disagreement. Any process with competing definitions of “the right way” introduces ambiguity an agent cannot resolve. 3. Validate that the remaining workflows have clear, bounded decision paths. Only workflows with predictable inputs and outputs can support safe, production‑grade automation. Art suggests that when teams apply these criteria rigorously, they often see dramatically faster progression to production. In his experience, narrowly scoped workflows that are already well understood internally can move to production several times faster than workflows burdened by ambiguity or internal disagreement. Applying this sequence shifts how leaders select initial use cases. The first AI workflow is not the one with the highest theoretical upside — it is the one already executed with clarity and consistency. In regulated environments, reliability follows alignment: when the underlying work is trusted, agents can reach production without triggering rework, exception handling, or governance friction. Composable AI ecosystems as the cure for vendor overload Art argues that the real barrier to enterprise AI adoption is architectural ambiguity, not vendor volume. Without a clear model of the system they are trying to build, decision‑makers treat every vendor pitch as adjacent, every capability as plausible, and every pilot as potentially relevant. The result is vendor overload driven by a lack of structure, not by market size. His solution is to define the AI system before selecting any components. Art calls this the ecosystem harness — a fixed map of capability blocks that represent the architecture the enterprise intends to operate. Once the harness exists, vendors are evaluated only within the specific capability box they claim to fill. The harness shifts vendor evaluation through three architectural principles: Categorical precision: Every vendor must map cleanly to a single capability block — data access, workflow orchestration, model execution, evaluation, governance, or integration. Vendors that cannot be placed are not part of the system. Noise elimination: Once capability blocks are defined, most vendor pitches become irrelevant by design. Leaders stop reacting to the market and start filtering through architecture. Scalable interlock: Pilots only proceed when the vendor’s capability can connect to the rest of the system. This prevents tools that solve a single workflow from scaling across the enterprise. The practical outcome is a shift from vendor‑driven exploration to architecture‑driven assembly. Instead of searching for “end‑to‑end platforms,” leaders construct a system from discrete, interoperable components. The harness serves as the mechanism that reduces vendor overload, aligns procurement with architecture, and ensures that every selected capability contributes to a system that can reach production and scale. Atomic workflow slices as the practical unit of agent deployment Art’s experience in pharma and life sciences highlights a structural reality: regulated workflows are too entangled, too dependent on legacy logic, and too cross‑functional to automate end‑to‑end in a single motion. Attempts to automate the whole process collapse under the weight of inherited complexity. Progress becomes possible when leaders isolate a single, self‑contained workflow slice that can be rebuilt cleanly and deployed independently of the broader system. Art explains the dynamic: “Systemic dependencies trap regulated workflows in gridlock. You only get deployable AI when you carve out a self‑contained slice that can run end‑to‑end without depending on the whole legacy process. Strip away inherited logic, rebuild that slice cleanly, and prove it can operate on its own. One contained win creates momentum that survives the complexity around it.” —Art Shectman, CEO of Elephant Ventures Based on Art’s experience, teams that adopt this approach are often able to deliver initial agent deployments within a matter of weeks to a few months, particularly when the workflow slice is truly decoupled and clearly defined. These early deployments frequently unlock meaningful efficiency gains by reducing manual effort in targeted parts of the workflow. The strength of Art’s insight is in the practical definition of what makes a workflow slice “atomic” in regulated environments: Decoupled from systemic dependencies: The slice must operate end‑to‑end without relying on upstream committees, cross‑functional approvals, or legacy systems that introduce delay or ambiguity. If it cannot run independently, it is not atomic. Stripped of inherited logic: Regulated workflows often contain steps justified only by history. Atomic slices are rebuilt from first principles: what is actually required for compliance, safety, and scientific rigor. Everything else is removed. Unambiguous decision paths: Every step must have explicit inputs, explicit outputs, and explicit criteria: no undocumented exceptions, no tribal knowledge, no interpretive judgment calls. Ambiguity is the enemy of agent reliability. Small enough to deploy, large enough to matter: The slice must be narrow enough to rebuild cleanly, but meaningful enough to demonstrate real operational value. This is not “micro‑tasking”; it is isolating a coherent, end‑to‑end unit of work. Art’s approach becomes a repeatable execution pattern for regulated teams: Choose one workflow slice that a single accountable team can own. Remove inherited steps until the slice is fully self‑contained. Rebuild the slice end‑to‑end with agents, instrumentation, and explicit decision criteria. Deploy and measure the slice as a contained operational win—not a transformation program. This reframes how regulated enterprises deploy agents. The practical unit of progress is not the full workflow but the atomic slice: small enough to rebuild cleanly, clear enough to [truncated for AI cost control]